Covid19, Neonatal Infection, Pregnancy Related, Vertical Transmission of Infectious Disease
Conditions
Keywords
Childbirth, COVID-19, Neonatal outcomes, Newborn, Pregnant women, Vertical transmission
Brief summary
A case-control trial was conducted to test the early postpartum period clinical outcomes of newborns born to pregnant women with and without COVID-19.
Interventions
Retrospectively reviewed clinical records and laboratory results
Sponsors
Study design
Eligibility
Inclusion criteria
Pregnant women on labor or preterm labor. Pregnant women who underwent programmed or emergence cesarean
Exclusion criteria
Those who were transferred to another hospital without or within a short period of delivery
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Vertical transmission | 48 hours after birth | Determine the prevalence of COVID-19 in newborns born to pregnant women with COVID-19 with PCR from a nasopharyngeal swab. |
| Neonatal birth outcomes | At birth | Determine the neonatal outcomes of the newborn specifying the birth week of the newborn, delivery type (vaginal or cesarean), birth weight (g), APGAR scores in the first and fifth minutes after birth. |
| Neonatal postnatal outcomes | Within 48 hours after birth | Determine the prevalence of neonatal postnatal outcomes of the newborn specifying the respiratory system illness, intensive care need, oxygen need, neonatal mortality, general health status, and breastfeeding status. |
Countries
Turkey (Türkiye)